Skip to content
★ Sign in to follow
RM

Ronald M. Lindsay

Executive
Sequenom IncArqule Inc
Total declarations
35
Companies
2
▲ Purchases (18 ops.)
€513k
▼ Sales (0 ops.)
—

Latest filing published 16 Jan 2020 for ARQULE INC, €1.1M.

Filing timeline

BuySale
Ronald M. Lindsay

Insider track record

Disclosed buys
18
Disclosed sells
0
Signal history

Closed purchases

Market purchases
18

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Ronald M. Lindsay: trading record in brief

Ronald M. Lindsay discloses dealings in 2 companies, chiefly Sequenom Inc and Arqule Inc. In total, 35 filings cover trades dated from 29 November 2006 to 16 January 2020.

No open-market sale appears; the market trades are 18 purchases worth €513k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 12 share grants and 3 option exercises.

Half of the purchases are above €12k and half below.

The record was last updated on 16 January 2020 with a transaction (€1.1M) in Arqule Inc. The most recent open-market purchase was published on 15 May 2018, 3,099 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Ronald M. Lindsay

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations34 total
  • ●
    DirectorExecutivesArqule Inc
    1M USD19SEC
    60,800 shares@ US$20.0097.0% of flowCommon StockSEC:0001104659-20-004727:0
  • ◇
    DirectorExecutivesArqule Inc
    38,700 USD15SEC
    10,000 shares@ US$3.872.9% of flowCommon StockSEC:0001019695-19-000015:0
  • ▲
    DirectorExecutivesArqule Inc
    18,561 USD25SEC
    6,900 shares@ US$2.691.3% of flowCommon StockSEC:0001019695-18-000017:0
    Canonical exit: 9 Aug 2018 (T+90)
  • ▲
    DirectorExecutivesArqule Inc
    63,813 USD23SEC
    23,900 shares@ US$2.674.5% of flowCommon StockSEC:0001019695-18-000012:0
    Canonical exit: 8 Aug 2018 (T+90)
  • ●
    DirectorExecutivesSequenom Inc
    0SEC
    209,804 sharesCommon StockSEC:0001209191-16-140419:0
  • ◇
    DirectorExecutivesSequenom Inc
    0SEC
    5,362 sharesCommon StockSEC:0001193614-16-000073:0
  • ◆
    DirectorExecutivesSequenom Inc
    0SEC
    2,025 sharesCommon StockSEC:0001193614-16-000073:1
  • ◇
    DirectorExecutivesSequenom Inc
    0SEC
    5,363 shares0Common StockSEC:0001193614-15-000019:0
  • ◆
    DirectorExecutivesSequenom Inc
    0SEC
    5,363 shares0Common StockSEC:0001182615-14-000043:0
  • ◆
    Executive VP, R&DExecutivesSequenom Inc
    0SEC
    30,000 shares0Common StockSEC:0001321466-13-000088:0
  • ◆
    Executive VP, R&DExecutivesSequenom Inc
    41,272 USD0SEC
    9,780 shares@ US$4.22Common StockSEC:0001321466-13-000088:1
  • ▲
    Exec VP, R&DExecutivesSequenom Inc
    266,295 USD0SEC
    88,765 shares@ US$3.00Common StockSEC:0001241032-12-000007:0
    Canonical exit: 30 Oct 2012 (T+90)
  • ▲
    Exec VP, R&DExecutivesSequenom Inc
    1,794 USD0SEC
    600 shares@ US$2.99Common StockSEC:0001241032-12-000007:1
    Canonical exit: 30 Oct 2012 (T+90)
  • ▲
    Exec VP, R&DExecutivesSequenom Inc
    1,188 USD0SEC
    400 shares@ US$2.97Common StockSEC:0001241032-12-000007:2
    Canonical exit: 30 Oct 2012 (T+90)
  • ▲
    Exec VP, R&DExecutivesSequenom Inc
    2,960 USD0SEC
    1,000 shares@ US$2.96Common StockSEC:0001241032-12-000007:3
    Canonical exit: 30 Oct 2012 (T+90)
  • ▲
    Exec VP, R&DExecutivesSequenom Inc
    7,670 USD0SEC
    2,600 shares@ US$2.95Common StockSEC:0001241032-12-000007:4
    Canonical exit: 30 Oct 2012 (T+90)
  • ▲
    Exec VP, R&DExecutivesSequenom Inc
    9,669 USD0SEC
    3,300 shares@ US$2.93Common StockSEC:0001241032-12-000007:5
    Canonical exit: 30 Oct 2012 (T+90)
  • ▲
    Exec VP, R&DExecutivesSequenom Inc
    3,212 USD0SEC
    1,100 shares@ US$2.92Common StockSEC:0001241032-12-000007:6
    Canonical exit: 30 Oct 2012 (T+90)
  • ▲
    Exec VP, R&DExecutivesSequenom Inc
    972 USD0SEC
    335 shares@ US$2.90Common StockSEC:0001241032-12-000007:7
    Canonical exit: 30 Oct 2012 (T+90)
  • ▲
    Exec VP, R&DExecutivesSequenom Inc
    5,453 USD0SEC
    1,900 shares@ US$2.87Common StockSEC:0001241032-12-000007:8
    Canonical exit: 30 Oct 2012 (T+90)
  • ◆
    Exec VP, R&DExecutivesSequenom Inc
    0SEC
    4,000 shares0Common StockSEC:0001454522-12-000015:0
  • ◆
    Exec VP, R&DExecutivesSequenom Inc
    7,065 USD0SEC
    1,436 shares@ US$4.92Common StockSEC:0001454522-12-000015:1
  • ◆
    Exec VP, R&DExecutivesSequenom Inc
    0SEC
    4,000 shares0Common StockSEC:0001454522-12-000015:2
  • ◆
    Exec VP, R&DExecutivesSequenom Inc
    0SEC
    1,001 shares0Common StockSEC:0001454522-12-000015:4
  • ◆
    Exec VP, R&DExecutivesSequenom Inc
    1,766 USD0SEC
    359 shares@ US$4.92Common StockSEC:0001454522-12-000015:5

25 of 34 declarations